FDA Vaccine Chief Dr. Vinay Prasad to Depart in April Dr. Vinay Prasad, the director of the Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research, will abandon …
Amgen Inc
-
-
Key Takeaways from Jim Cramer’s Healthcare Sector Analysis: Here’s a breakdown of the main points from Jim Cramer’s analysis, geared towards potential investment opportunities: Overall Sentiment: Cramer is bullish on …
-
Novo Nordisk‘s shift from a market darling to a serious underperformer has set the stage for a transitional 2026 as the Danish drugmaker fights to regain investor confidence in its …
-
Zealand Pharma Outlines Ambitious 5-Year Obesity Drug Strategy Amidst Growing Competition Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for it’s anti-obesity portfolio …
-
A combination image shows an injection pen of Zepbound, eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters Teh appetite for blockbuster …